More Hanx Biopharmaceuticals (Wuhan) Co. Ltd. news
Hanx Biopharmaceuticals (Wuhan) Co. Ltd.HKEX: 3378

Next Day Disclosure Return

Jun 29, 2026 at 6:53 AM EDT · Issued by Hanx Biopharmaceuticals (wuhan) Co. Ltd. via HKEXnews

Filed with HKEX · Jun 29, 2026 at 6:53 AM EDT · 6 pages · English

On 6ix: 6ix.com/news/next-day-disclosure-return-40

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. on 6ix

Earlier from Hanx Biopharmaceuticals (Wuhan)

  • Voluntary announcement notice on voluntary extension of lock-up period by shareholdersJun 24
  • Voluntary announcement inclusion of Hanx Biopharmaceuticals in the FTSE global micro cap indexJun 22

Later from Hanx Biopharmaceuticals (Wuhan)

  • Proposed placing of unlisted warrants under Specific mandateSep 13
  • 2026 Interim reportSep 21
  • Voluntary announcement entering into strategic cooperation with xtalpiSep 21
  • Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026Oct 5
All Hanx Biopharmaceuticals (Wuhan) news releases↗

Follow Hanx Biopharmaceuticals (Wuhan) into a list and get an email when it puts out news.

Follow Hanx Biopharmaceuticals (Wuhan)
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer